Amaç: Elajik asit bitkilerden elde edilen polifenolik bir bileşiktir. Bu çalışmanın amacı, elajik asidin sıçan C6 glioma hücre dizilerinde proliferasyon ve yaşama yeteneği üzerine in vitro etkilerini doz ve zamana bağlı olarak araş-tırmak ve C6 glioma küremsi cisimlerinde oluşan elektronmikroskopik değişiklikleri değerlendirmektir.
Materials and methods:
Effects of ellagic acid on rat C6 glioma cell line were investigated by using two-dimensional models of tumor cell culture depending on dose and time. The effects of Ellagic acid was evaluated as cell proliferation, cell viability, and synthesis phase of cell cycle, and cell structure at 24 th , 48 th , 72
nd hours. Cell structure was evaluated at 24 th and 72 nd hours in three dimensional cell culture spheroid models.
Results:
Reducing effect of ellagic acid on cell proliferation and cell viability was seen in two dimensional cultures (p<0.05). Increment or decrement were not seen in synthesis phase in two dimensional cultures (p>0. 05). Electron micrographs in which three dimensional cell culture spheroid models was investigated, structural changes was found to be different from the control group.
INTRODUCTION
Glioblastoma multiforme which is the most commonly seen primary brain tumor disseminates quickly. Treatment is surgical excision, postoperative radioterapy and chemoterapy. Unfortunately the mean survival is less than one year despite all treatment. There is no definitive treatment. New treatment options are being waited. Ellagic acid which is found in pomegranate, strawberries, raspberries, walnuts is phytochemical polyphenol compound. [1] [2] [3] [4] [5] It is showed that, ellagic acid reduces growth of breast cancer, esophagus cancer, colon cancer, leukemia and neuroblastoma in cell culture studies. [6] [7] [8] Ellagic acid/chitosan composite biomaterial leads cancer cells to apoptosis in one layer cell culture in a study with using U87 glioblastoma and rat C6 glioma cell lineage. 9 In this study we investigate in vitro effects of ellagic acid on the proliferation and viability of rat C6 glioma cell lineage.
MATERIALS AND METHODS
Rat C6 glioma cell line (ECACC no: 558807), which was taken from American Type Culture Collection was used in Laboratory of Istanbul University Histology and Embriology Department for this study.
a. Ellagic acid preparation for proliferation experiment: Ellagic acid which was taken 2mg has 302.192 g/mol molecular weight and it was dissolved in 1324 µl DMSO (Dimethyl sulfoxide) so 5 mM ellagic acid stock solution was obtained by dilution of stock solution with DMSO. 50, 10, 1 µM application concentrations were reached by 100 µl adding these doses to 5 ml wells containing medium.
b. Experiment protocols in which ellagic acid doses were used: 100% live 500000 C6 glioma cells were inoculated in 5 ml DMEM/F12 (Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12) medium in each wells of six-well plate. Groups were determined as control group, 1 µM, 10 µM, 50 µM and 100 µM groups. Only 100 µl DMSO was given to control group. C6 glioma cells inoculation were performed in three wells for each Ellagic acid dose and control group. All groups were inoculated separately for 24, 48 and 72 hours drug application and incubation was performed in a moist environment with 37°C and 5% CO 2 air-mixture.
At the end of 24, 48 and 72 hours cells were collected separately from all experimental and control with 0.05% trypsin wells and these cells were centrifuged. After discard of supernatant part, suspension was made with 1ml medium and it was counted in counting chamber. Total cell counts were recorded to determine the proliferation rate. Cell suspension was mixed with 0.1% trypan blue dye with equal proportion. A drop of suspension was taken and stained dead cells and unstained live cells were counted under microscope so live cell ratio was determined (Table 1) . c. Immunohistochemical marking with Brdu in two-dimensional cell culture: Round lamellas were placed in 24 wells culture plates and 40000 cells were inoculated in each wells. Cell culture medium 1 ml was placed in each well. Doses required for 1 µM, 10 µM, 50 µM and 100 µM ellagic acid groups are prepared from stock ellagic acid groups and 20 µl applications were done. 20 µl DMSO was applicated to control group. Three lamellae were prepared for each group. At the end of 24, 48 and 72 hours, cells were incubated with 20 µM BrdU (Bromodeoxyuridine) (2ml medium+100µl BrdU) for 1 hour at 37°C. After upper medium was retreated and thrown, 1 ml sterile PBS (Phosphate buffer) solution was applicated into the wells and stored in the incubator for 15 minutes. Cells were fixated in 70% ethanol in -20°C for 30 minutes after retreat and thrown of PBS. Lamellae were dried at room temperature after ethanol was retreated. Dried lamellae for immunohistochemistry was rehydrated in PBS for 10 minutes then it was kept in 5% H 2 O 2 prepared in methanol for hydrogen peroxide inhibition in the dark. After application of ultra-V-block for 15 minutes in room temperature and humid environment to avoid non-specific antibody binding, it was kept in anti-BrdU antibody (NCL-BrdU; Zymed 1/50) for an hour. After washing with PBS it was kept in secondary antibody for 30 minutes, after washing again it was kept in streptavidin peroxidase for 30 minutes. After washing with PBS it was kept in AEC chromogenic-substrate solution (AEC Substrate System; Zymed) for 20 minutes and then it was washed with distilled water. After floor stain- 
d. Preparation of three dimensional cultures for electron microscopic evaluation:
Inoculation was done for three dimensional cultures in agar coated cell culture dishes. 500000 cells in 5 ml DMEM/F12 medium were inoculated into the each wells coated with solidified agar. Inoculation was done into the 6 wells for each control group, 1 µM and 100 µM ellagic acid groups. Mediums which were done in each 48 hours were waited for 7 days to form the spheroids from cells kept in incubator. While dose required for 100 µM ellagic acid group was applicated directly from ellagic acid solution, dose required for 1 µM ellagic acid group was prepared by dilution and 100 µl applications were done. 100 µl DMSO was applicated to control group. Spheroids were collected at 24 th and 72 nd hours and placed into different centrifuge tubes. After upper medium was retreated and thrown,1 ml 0.1 M phosphate buffered 2.5% gluteraldehyde solution was added and fixated under 4°C for 30 minutes. Post-fixation with 1% OsO4 for 60 minutes under 4°C was done after centrifuge and washing 2 times with phosphate buffer. After washing again with phosphate buffer for 10 minutes it was kept in 1% uranil acetate for 15 minutes. It was kept in 30% ethanol after phosphate buffer washing for 10 minutes. After that, it was kept in 50% ethanol for 10 minutes then 70% ethanol for 10 minutes then 90% ethanol twice for 10 minutes then pure propylenoxide for 10 minutes then 1/1 ratio prepared propyleneoxide/epone mixture for 1 hour and finally it was kept in pure epone for 1 hour. After that it was embedded in tissue embedding capsules. It was kept in 37°C in the incubator for 18 hours. After trim of blocks which was taken from the incubator, target sections containing spheroids in 1 µm semi-thin sections was detected. Then 70 nm thin sections on copper grids were done. It was evaluated under transmission electron microscopy after lead citrate and uranyl acetate contrasting.
e. Statistical analysis: Statistical analyses were performed under the SPSS for Windows software (version 12, SPSS Inc, Chicago, IL). Independent Student's T-test was used in all experimental results. Results are presented as mean ± standard deviation and ranges. A two-tailed probability of 5% or less was considered statistically significant. On the other hand this concentration increased live cell ratio at 48 th hour significantly. Significant changes were not observed compared to control group in live cell ratio with 10 µM application of ellagic acid. 100 µM ellagic acid caused statistically significant reduction in the live cell ratio with compared to control group at 24 th hour (p<0.01) (Graphic 2).
RESULTS

c. Effects of different concentration of ellagic acid on BrdU marking index (BrDU-LI):
Application of 1 µM concentration of ellagic acid cause increment at all times in BrDU-LI (Thymidine labeling index) values with compared to control group while this increment was statistically significant at 24 th hour (p<0.05). BrDU-LI values were increased at 24 th and 72 nd hour with compared to control group by application of 10 µM concentration of ellagic acid whereas increment in 24 th hour was statistically significant (p<0.01). Application of 50 µM concentration of ellagic acid cause increment at all times in BrDU-LI values with compared to control group whereas increment in 24 th and 48 th hour were statistically significant (p<0.0001, p<0.0001). BrDU-LI values were significantly increased at all times with compared to control group by application of 100 µM concentration of ellagic acid (p<0.05, p<0.001, p<0.001) (Graphic 3; Picture 1, 2). d. Electron microscopic evaluation of three dimensional cell cultures: Tight regulations depending on 3 dimensional cellular contacts of C6 glioma cells generated an appearance similar to a typical tumor tissue to the spheroid in the control group at 24 th hour. Glioma cells which form spheroids have one nucleolus or two nucleoli and recessed and protruding euchromatic nucleus and their cytoplasms were seen electron-light in some cells and electron-dense in the other cells. Shelfshaped mitocondria with crista were seen less in some cells and more in the other cells. Plasma membranes of cytoplasm of adjacent cells were located closely in the outer surface of the spheroids and gaps which have 20 to 500 nm width contain electron dense material in some parts were found between two cell membranes. Plasma membrane gaps which did not contain electron dese material have 4-14 nm width. Microvilli like amorphous extensions formed by plasma membranes were in contact with each other in the intercellular space inside of the spheroid. As well as, inside spheroids in some cells electron dense material containing vacuoles surrounded by membrane and wide intercellular space were seen (Picture 3).
Necrotic area which was expected in a typical spheroid structure was not seen in this group spheroid. At the 24 th hour application of 1 µM ellagic acid, inside electron dense cytoplasm of tumor cells forming spheroid, rich free ribosome and electron dense matrix, mitocondria with weak crista were drew attention. Connections between cells of outer surface of the spheroids were disappeared in some places and just below these cells wide intercellular spaces were occurred. In these wide intercellular spaces extending into the inner parts of the spheroids debris materials belonging to degenerated cells were found and in the cytoplasmic parts facing to these areas electron dense material containing vacuoles were seen.
At the 24 th hour ellagic acid application of 100 µM concentration, degenerated cell debris containing intercellular space widening were seen near the outer surface of the spheroids and this was similar to 24 th hour of 1 µM ellagic acid application results.
At the 72 nd hour of 1 µM application of ellagic acid, necrotic cells and apoptotic bodies were drew attention in the wide intercellular spaces inside the spheroids.
Near the outside face of the spheroids and inside of the spheroids intercellular space widening areas were found at 72 nd hour of application of 100 µM ellagic acid. In these areas microvillus like amorphous extensions were abundant and degenerated cell debris was not found (Picture 3, 4, 5). Statistical evaluation results: As a result in two dimensional cell culture model ellagic acid led to reduction in cell proliferation with compared to control group. In S-phase evaluation ellagic acid led to increment in all concentration. Live cell ratio was increased at 48 th hour, decreased in other intervals.
DISCUSSION
In our study, we found that ellagic acid reduced cell proliferation and viability ratio in C6 glioma cells which was dose and time dependent. Statistically significant cell proliferation reduction was seen in 1,50, 100 µM doses of ellagic acid at 48 th hour and 1,10µM doses at 72 nd hour. As well as statistically significant reduction in cell proliferation was seen in 1µM dose at 72 th hour, 50µM dose at 48 th hour, 100µM dose at 24 th hour.
Studies to clarify the mechanism of antitumoral effects of ellagic acid reported that drug did not cause any change in expression level of tumor suppressor gene P53 but it increase expression of cyclin-dependent kinase inhibitor p21 (waf1/Cip1). 10 On the other hand ellagic acid increases cytochrome c level released from mitochondria to the cytosol and it increases caspase-3 and caspase-9 which are important proteases. It is reported that in this way ellagic acid induced apoptosis.
11
In a study on SH-SY5Y human neuroblastoma cells, ellagic acid decreased cells in S phase compared to control group and this was statistically significant, whereas cells in G2/M phase were slightly increased and cells in G0/G1 phase were significantly increased. 12, 13 Mertens et al. reported that 10 µM ellagic acid application did not effect in MOLT-4 human leukemia cell cycle compared to control group at 12 th , 24 th and 48 th hour. 14 In a study on CaSki cervical cancer cells 10 µM ellagic acid stops cell cycle in G1 phase. 10 Li et al. reported that, 5, 10, 25 and 50 µM doses of ellagic acid increased the cell ratio in G0/G1 phase of cell cycle and decreased cell ratio in G2/M phase of cell cycle in T24 human bladder cancer cells. 15 In our study, effect of different concentration of ellagic acid on S phase of C6 glioma cell cycle which was expressed as BrdU-LI was increased with compared to control group in all concentrations and in time period and no decrement was seen in all concentrations and in time period. This result was in line with a study about effects of ellagic acid on Caco-2 human colon cancer cell descendants by Larossa et al. In this study 1, 10 and 30 µM doses of ellagic acid were applicated at 24 th , 48 th and 72 nd hour and cyclin levels were investigated. It was reported that ellagic acid reduced cyclin A and B1 and it increased cyclin E levels with related to time and dose so cell was arrested at S phase of the cell cycle. 11 This study supports our finding that is while ellagic acid reduced cell proliferation and viability and it increased the cell ratio in S phase expressed as BrdU-LI value.
Different mutations in a particular cell's descendants may cause the diversity of polyphenol treatment outcomes and the cell cycle halt in different phases. In our study, effects of ellagic acid on cell viability and proliferation showed different statistical significance lines during administered dose and time interval. Effects of ellagic acid on the cell cycle may have temporary features and pathways to es- cape from cell destruction may arise in tumor cell population. 11, 12, [14] [15] [16] [17] To our knowledge this study which evaluates effects of ellagic acid in three dimensional spheroid model by using electron microscopy is the first study. Taking into account the three-dimensional arrangement of solid tumors multicellular tumor spheroids which were developed to form more suitable in vitro systems reflect three dimensional growth and organizations of tumors quite realistically, as a result intercellular relations in tumor and microenvironmental conditions can be presented clearly. 18 Integrins have major role in cell-cell contact in spheroids. Integrins which bind to spheroid cell skeleton also bind intercellular matrix. In this way, cell-cell connection and spheroid integrity can be provided. It is known that integrin release is organized by spheroid microenvironment. 19 In our study, connections between cells located in the outer surface of the C6 glioma spheroids were disappeared in some places and just below these cells wide intercellular spaces were occurred.
In these wide intercellular spaces extending into the inner parts of the spheroids debris materials belonging to degenerated cells were seen. In our study, this condition with reduction in cell proliferation and cell viability caused by ellagic acid effect integrin release organized by spheroid microenvironment and reduce connections of the cells in each other and external matrix.
In the way of these findings, microscopic and molecular studies are needed to find mechanism of effects of ellagic acid on different cell types and further studies are needed to find synergistic effects of this drug in combination with different chemotherapeutic agents.
In conclusion, ellagic acid which reduced cell proliferation and cell viability increased BrdU-LI showing S phase of the cell cycle in C6 glioma cells.
